First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 24, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2027

Conditions
Select Advanced Solid Tumors
Interventions
BIOLOGICAL

CDR404

IV infusions

Trial Locations (17)

1070

RECRUITING

Institut Jules Bordet, Brussels

1200

RECRUITING

Cliniques Universitaires Saint-Luc, UCL Ouvain, Brussels

2650

RECRUITING

Universitair Ziekenhuis Antwerpen, Antwerp

9000

RECRUITING

Universitair Ziekenhuis Gent, Ghent

19106

RECRUITING

Pennsylvania Hospital, Philadelphia

20089

RECRUITING

Istituto Clinico Humanitas, Milan

20141

RECRUITING

Isituto Europeo di Oncologia (IEO), Milan

28041

RECRUITING

Hospital 12 de Octubre, Madrid

28050

RECRUITING

START Madrid, Madrid

33136

RECRUITING

University of Miami, Miami

46026

RECRUITING

Hospital Universitari i Politecnic La Fe, Valencia

RECRUITING

Instituto de Investigacion Sanitaria (INCLIVA), Valencia

48109

RECRUITING

University of Michigan, Ann Arbor

97213

RECRUITING

Providence Cancer Institute, Portland

DK-2100

RECRUITING

Rigshospitalet, Copenhagen

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

08908

RECRUITING

Institut Catala d'Oncologia, L'Hospitalet de Llobregat (ICO), Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CDR-Life AG

INDUSTRY